ProtoKinetix, Incorporated
PKTX
Rank in Stocks
#33092
ProtoKinetix, Incorporated is a biotechnology firm engaged in research and... ProtoKinetix, Incorporated is a biotechnology firm engaged in research and development, specializing in the scientific and medical investigation of glycoproteins known as anti-freeze glycoproteins (AFGPs) and anti-aging glycoproteins (AAGPs). These AFGPs are particularly relevant for their commercial potential within the healthcare sector, with a key area of their development involving utilizing AAGPs for the treatment of dry-eye conditions. Their research efforts are bolstered by a collaborative agreement with the University of British Columbia. Originally incorporated in 1999 as RJV Network, Inc., the company adopted its current name, ProtoKinetix, Incorporated, in July 2003. Its operational headquarters are situated in Marietta, Ohio.
Share Price
$0.002
Last synced: 2026-11-10
Market Cap
$815.98K
Change (1 day)
900.00%
Change (1 year)
-70.59%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade ProtoKinetix, Incorporated (PKTX)
Category
Healthcare
EPS for ProtoKinetix, Incorporated (PKTX)
EPS as of December 2025 TTM: $0.00
According to ProtoKinetix, Incorporated's latest financial reports, its current EPS (TTM) is $0.00. At the end of 2025 the company had an EPS of 0.00, equal to its 2024 EPS of 0.00.
EPS history for ProtoKinetix, Incorporated from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | -100.00% |
| 2025 | 0.00 | -100.00% |
| 2024 | 0.00 | -90.00% |
| 2023 | $-0.01 | 61.29% |
| 2022 | $-0.01 | -22.50% |
| 2021 | $-0.01 | -70.80% |
| 2020 | $-0.03 | 75.64% |
| 2019 | $-0.02 | 231.91% |
| 2018 | 0.00 | -22.95% |
| 2017 | $-0.01 | -4.69% |
| 2016 | $-0.01 | 10.34% |
| 2015 | $-0.01 | 480.00% |
| 2014 | 0.00 | -69.70% |
| 2013 | 0.00 | 120.00% |
| 2012 | 0.00 | -88.64% |
| 2011 | $-0.01 | -28.26% |
| 2010 | $-0.02 | -11.96% |
| 2009 | $-0.02 | -23.16% |
| 2008 | $-0.03 | -54.36% |
| 2007 | $-0.06 | 30.99% |
| 2006 | $-0.05 | -65.00% |
| 2005 | $-0.13 | -27.78% |
| 2004 | $-0.18 | 218.58% |
| 2003 | $-0.06 | 9,316.67% |
| 2002 | 0.00 | 0.00% |
| 2001 | 0.00 | 0.00% |
| 2000 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -2,610,100.00% |
US
|
|
| $-7.07 | 1,178,233.33% |
US
|
|
| $-5.29 | 881,566.67% |
AU
|
|
| $12.88 | -2,146,783.33% |
BE
|
|
| $21.56 | -3,593,433.33% |
NL
|
Questions about ProtoKinetix, Incorporated's earnings per share (EPS)
What is ProtoKinetix, Incorporated's earnings per share (EPS)?
ProtoKinetix, Incorporated's earnings per share (EPS) over the last twelve months is $0.00, as of Dec 2025.
What was ProtoKinetix, Incorporated's earnings per share (EPS) in 2025?
In 2025, ProtoKinetix, Incorporated's earnings per share (EPS) was 0.00, compared with 0.00 in 2024.
How has ProtoKinetix, Incorporated's earnings per share (EPS) changed since 2020?
From 2020 to 2025, ProtoKinetix, Incorporated's earnings per share (EPS) was highest in 2025 (0.00) and lowest in 2020 ($-0.03).
How does ProtoKinetix, Incorporated's earnings per share (EPS) compare with similar companies?
ProtoKinetix, Incorporated's earnings per share (EPS) ($0.00) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.